challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer挑战与酪氨酸激酶抑制剂治疗转移性甲状腺癌.pdfVIP

  • 1
  • 0
  • 约7.39万字
  • 约 10页
  • 2017-08-27 发布于上海
  • 举报

challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer挑战与酪氨酸激酶抑制剂治疗转移性甲状腺癌.pdf

challenges associated with tyrosine kinase inhibitor therapy for metastatic thyroid cancer挑战与酪氨酸激酶抑制剂治疗转移性甲状腺癌

SAGE-Hindawi Access to Research Journal of Thyroid Research Volume 2011, Article ID 985780, 9 pages doi:10.4061/2011/985780 Review Article Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer Maria E. Cabanillas,1 Mimi I. Hu,1 Jean-Bernard Durand,2 and Naifa L. Busaidy1 1 Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 2 Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, US

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档